Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience

被引:4
|
作者
Xu, Benjie [1 ]
Zhu, Jiahao [1 ]
Wang, Ren [1 ]
Pang, Xiangyi [1 ]
Wang, Xin [1 ]
Lian, Jie [1 ,2 ]
Lu, Haibo [1 ,2 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Peoples R China
[2] Harbin Med Univ, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Naples prognostic score; cholangiocarcinoma; nomogram; overall survival; real-world experience; INFLAMMATION;
D O I
10.2147/JIR.S446735
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: The Nutritional Prognostic Score (NPS) is a composite indicator that effectively reflects the preoperative nutritional and inflammation status of patients. Its prognostic value has been extensively confirmed in various types of tumors. Our study aims to investigate the clinical implications of the NPS in the postoperative patients with cholangiocarcinoma (CCA). Patients and Methods: Data on clinicopathological characteristics were collected from CCA patients who underwent radical surgery between 2014 and 2019 at Harbin Medical University Cancer Hospital. NPS was calculated using relevant indicators to categorize the patients, and association of NPS with clinicopathological characteristics and survival outcomes were analyzed. To assess differences in survival rates between different groups, we utilized the Kaplan -Meier method. Independent prognostic risk factors were identified by Cox regression analysis. A CONomogram was created, and its accuracy in survival prediction was evaluated using receiver operating characteristic (ROC) curves. Independent verification was conducted in the validation group. Results: For this study, a cohort of 232 patients was enlisted and subsequently divided into training group (N=162) and validation group (N=70). An evident correlation was detected between NPS and preoperative malnutrition. Patients with higher NPS exhibited a worse overall survival (OS), with 5 -year OS rates of 79.1%, 33.1%, and 10.6%. Multivariate analysis revealed that NPS was an independent risk factor for OS in resected CCA patients (P<0.001). The NPS-based Nomogram was developed to accurately assess the risk of patients. Conclusion: The NPS was identified as a significant risk factor that impacts the prognosis of patients with resected CCA. In order to improve prognosis management, the NPS-based Nomogram has been demonstrated to be a precise and efficient tool.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 50 条
  • [21] Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
    Say, Timothy Lee Tang Lee
    Yang, Verlyn
    Fingret, Jacob M.
    Zagora, Sophia
    Symes, Richard
    Younan, Christine
    Cornish, Elisa Eleanor
    Verma, Nitin
    Sammel, Anthony
    Wakefield, Denis
    Speden, Deborah
    McCluskey, Peter J.
    BMJ OPEN OPHTHALMOLOGY, 2021, 6 (01):
  • [22] Real-world clinical experience with Obsidio Conformable Embolic
    Osman Ahmed
    John Karageorgiou
    Abhishek Kumar
    Mikin Patel
    Joshua Jones
    Nariman Nezami
    CVIR Endovascular, 8 (1)
  • [23] Initial experience with teriflunomide in a real-world clinical setting
    Duquette, P.
    Roger, E.
    Nadeau, N.
    Hum, S.
    Bigras, C.
    Despault, P.
    Lapierre, Y.
    Grand'Maison, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 243 - 243
  • [24] Cenobamate: Real-World Experience Matches Clinical Trials
    Aungaroon, Gewalin
    EPILEPSY CURRENTS, 2023, 23 (06) : 348 - 350
  • [25] The Gustave Roussy Immune score (GRIm score) as a novel prognostic score for early breast cancer patients: A real-world retrospective study
    Tan, Chunlei
    Xu, Jinling
    Yang, Xiaotian
    Wu, Danping
    Zhang, Shiyuan
    Liu, Shuqiang
    Yu, Boqian
    Huang, Yuanxi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (14): : 2640 - 2654
  • [26] Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study
    Ottaiano, Alessandro
    Santorsola, Mariachiara
    Diana, Anna
    Belli, Andrea
    Lentini Graziano, Maria Luisa
    Orefice, Jessica
    Patrone, Renato
    Di Mauro, Annabella
    Scognamiglio, Giosue
    Tatangelo, Fabiana
    De Bellis, Mario
    Piccirillo, Mauro
    Fiore, Francesco
    Stilo, Salvatore
    Tarotto, Luca
    Correra, Marco
    Di Lorenzo, Sara
    Capuozzo, Maurizio
    Avallone, Antonio
    Silvestro, Lucrezia
    Bianco, Antonella
    Granata, Vincenza
    Federico, Piera
    Montesarchio, Vincenzo
    Daniele, Bruno
    Izzo, Francesco
    Nasti, Guglielmo
    CANCER MEDICINE, 2024, 13 (04):
  • [27] Real-world experience with sunitinib treatment in patients with metastatic renal cell carcinoma: Clinical outcome according to risk score.
    Schmidinger, Manuela
    Porta, Camillo
    Oudard, Stephane
    Denechere, Gwenael
    Brault, Yves
    Serfass, Lucile
    Costa, Nuno Matos
    Larkin, James M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Prognostic biomarkers for cholangiocarcinoma and their clinical implications
    Saengboonmee, Charupong
    Sawanyawisuth, Kanlayanee
    Chamgramol, Yaovalux
    Wongkham, Sopit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 579 - 592
  • [29] Ten years of experience in patients with resected pancreatic tumors: Real-world data in a public institution in Peru.
    Macetas, Jackeline
    Vallejos, Heberth Daniel
    Cabana, Eder Christian Veramendi
    Serrano, Mariana
    Pacheco, Cristian
    Oliden, Victor Castro
    Mantilla, Raul
    Montenegro, Paola Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 686 - 686
  • [30] An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort
    Becker, T.
    Weberpals, J.
    Jegg, A. M.
    So, W., V
    Fischer, A.
    Weisser, M.
    Schmich, F.
    Ruttinger, D.
    Bauer-Mehren, A.
    ANNALS OF ONCOLOGY, 2020, 31 (11) : 1561 - 1568